(Q33517859)

27 July 2017

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1. (English)

1 reference

27 July 2017

0 references

anti-retroviral agent

0 references

0 references

1

Christopher J Destache

1 reference

27 July 2017

Todd Belgum

2

1 reference

27 July 2017

Keith Christensen

3

1 reference

27 July 2017

Annemarie Shibata

4

1 reference

27 July 2017

Akhilesh Sharma

5

1 reference

27 July 2017

Alekha Dash

6

1 reference

27 July 2017

9 December 2009

1 reference

27 July 2017

BMC Infectious Diseases

1 reference

27 July 2017

9

1 reference

27 July 2017

198

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

1 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-9-198

0 references

cites work

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Adherence to enfuvirtide and its impact on treatment efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Nanotechnology: a focus on nanoparticles as a drug delivery system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Antiretroviral therapy in the developing world

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Nanoparticle and targeted systems for cancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

The global impact of HIV/AIDS

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

The role of mononuclear phagocytes in HTLV-III/LAV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807870

The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Re-emergence of HIV after stopping therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-198

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

21 January 2018

1 reference

12 December 2020

Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice

1 reference

12 December 2020

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

1 reference

12 December 2020

Infection of monocytes/macrophages by HIV in vitro

1 reference

12 December 2020

Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models

1 reference

12 December 2020

Mechanisms of HIV/SIV mucosal transmission

1 reference

12 December 2020

An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-9-198

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference